Authors:
GROSSEHOVEST L
BRANDL M
DOHLSTEN M
KALLAND T
WILMANNS W
JUNG G
Citation: L. Grossehovest et al., TUMOR-GROWTH INHIBITION WITH BISPECIFIC ANTIBODY FRAGMENTS IN A SYNGENEIC MOUSE MELANOMA MODEL - THE ROLE OF TARGETED T-CELL CO-STIMULATIONVIACD28, International journal of cancer, 80(1), 1999, pp. 138-144
Authors:
HABERL C
HULTNER L
FLUGEL A
FALK M
GEUENICH S
WILMANNS W
DENZLINGER C
Citation: C. Haberl et al., RELEASE OF PROSTAGLANDIN D-2 BY MURINE MAST-CELLS - IMPORTANCE OF METABOLITE FORMATION FOR ANTIPROLIFERATIVE ACTIVITY, Mediators of inflammation, 7(2), 1998, pp. 79-84
Authors:
BERTSCH F
MATTNER J
STEHLING MK
MULLERLISSE U
PELLER M
LOEFFLER R
WEBER J
MESSMER K
WILMANNS W
ISSELS R
REISER M
Citation: F. Bertsch et al., NONINVASIVE TEMPERATURE MAPPING USING MRI - COMPARISON OF 2 METHODS BASED ON CHEMICAL-SHIFT AND T-1-RELAXATION, Magnetic resonance imaging, 16(4), 1998, pp. 393-403
Authors:
HOLLER E
LEDDEROSE G
KNABE H
MUTH A
GUNTHER C
WILMANNS W
KOLB HJ
Citation: E. Holler et al., ATG SEROTHERAPY DURING PRETRANSPLANT CONDITIONING IN UNRELATED DONOR BMT - DOSE-DEPENDENT MODULATION OF GVHD, Bone marrow transplantation, 21, 1998, pp. 105-105
Authors:
GUENTHER C
HOLLER E
MUTH A
HUMANN M
LEDDEROSE G
HAHN J
WICK M
ROECKEN M
PLEWIG G
WILMANNS W
KOLB HJ
Citation: C. Guenther et al., INCIDENCE OF STREPTOCOCCUS-PNEUMONIAE INFECTION AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION, Bone marrow transplantation, 21, 1998, pp. 499-499
Authors:
SCHMETZER HM
MITTERMULLER J
DUELL T
WILMANNS W
Citation: Hm. Schmetzer et al., DEVELOPMENT OF MYELOMA AND SECONDARY MYELODYSPLASTIC SYNDROME FROM A COMMON CLONE, Cancer genetics and cytogenetics, 100(1), 1998, pp. 31-35
Authors:
GEUENICH S
HABERL C
EGGER D
KASPERS U
HULTNER L
WILMANNS W
DENZLINGER C
Citation: S. Geuenich et al., INDUCTION OF LEUKOTRIENE PRODUCTION BY BLEOMYCIN AND ASPARAGINASE IN MAST-CELLS IN-VITRO AND IN PATIENTS IN-VIVO, Biochemical pharmacology, 55(4), 1998, pp. 447-453
Authors:
HOLLER E
ERTL B
HINTERMEIERKNABE R
RONCAROLO MG
EISSNER G
MAYER F
FRAUNBERGER P
BEHRENDS U
PFANNES W
KOLB HJ
WILMANNS W
Citation: E. Holler et al., INFLAMMATORY REACTIONS INDUCED BY PRETRANSPLANT CONDITIONING - AN ALTERNATIVE TARGET FOR MODULATION OF ACUTE GVHD AND COMPLICATIONS FOLLOWING ALLOGENEIC BONE-MARROW TRANSPLANTATION, Leukemia & lymphoma, 25(3-4), 1997, pp. 217-224
Citation: Rt. Radulescu et al., LEUCINE-ZIPPER, NUCLEAR TARGETING AND P130 INTERACTION MOTIFS IN THE EPIDERMAL GROWTH-FACTOR PRECURSOR - THE NUCLEOCRINE CONNECTION FURTHERUNVEILED, European journal of cancer, 33, 1997, pp. 26-26
Authors:
GEUENICH S
HABERL C
EGGER D
KASPERS U
HULTNER L
SAGEBIELKOHLER S
WILMANNS W
DENZLINGER C
Citation: S. Geuenich et al., EFFECT OF BLEOMYCIN AND ASPARAGINASE ON LEUKOTRIENE PRODUCTION IN-VITRO AND IN-VIVO, European journal of cancer, 33, 1997, pp. 46-46
Authors:
HABERL C
FLUGEL F
GEUENICH S
HULTNER L
FALK M
WILMANNS W
DENZLINGER C
Citation: C. Haberl et al., INHIBITORY EFFECT OF PROSTAGLANDIN (PG) D-2, PGJ(2) AND DELTA(12)-PGJ(2) ON PROLIFERATION OF CELLS INVOLVED IN HOST-DEFENSE, European journal of cancer, 33, 1997, pp. 47-47
Authors:
MULLER Y
WIERENGA E
MAILHAMMER R
WILMANNS W
JUNG G
Citation: Y. Muller et al., REDUCTION OF CD3-MEDIATED APOPTOSIS IN HUMAN T-CELLS BY CD28-COSTIMULATION - POSSIBLE MECHANISMS, European journal of cancer, 33, 1997, pp. 82-82
Authors:
RADULESCU RT
LIU HY
ZHANG BY
WILMANNS W
NUSSLER V
Citation: Rt. Radulescu et al., RETINOBLASTOMA PROTEIN-DERIVED PEPTIDES - FURTHER DEFINITION OF THEIRPROPERTIES ANTINEOPLASTIC, European journal of cancer, 33, 1997, pp. 83-83
Citation: M. Brandl et al., GENERATION OF ANTITUMOR-ACTIVITY BY BISPECIFIC ANTIBODIES IN NON-HODGKIN-LYMPHOMA - IN-VITRO INHIBITION OF AUTOLOGOUS HEMATOPOIESIS, European journal of cancer, 33, 1997, pp. 94-94
Authors:
NUESSLER V
GULLIS E
PELKAFLEISCHER R
DELVALLE F
DIEM H
BEYERLEIN S
ZWIERZINA H
WILMANNS W
Citation: V. Nuessler et al., EXPRESSION AND FUNCTIONAL-ACTIVITY OF P-GLYCOPROTEIN IN ADULT ACUTE MYELOGENOUS LEUKEMIA PATIENTS, Annals of hematology, 75(1-2), 1997, pp. 17-26
Authors:
SCHMETZER HM
POLECK B
MITTERMULLER J
DUELL T
WILMANNS W
GERHARTZ HH
Citation: Hm. Schmetzer et al., CLONALITY ANALYSIS AS A TOOL TO STUDY THE BIOLOGY AND RESPONSE TO THERAPY IN MYELODYSPLASTIC SYNDROMES, Leukemia, 11(5), 1997, pp. 660-666
Authors:
NUESSLER V
GIESELER F
GULLIS E
PELKAFLEISCHER R
STOTZER O
ZWIERZINA H
WILMANNS W
Citation: V. Nuessler et al., FUNCTIONAL P-GP EXPRESSION IN MULTIPLE-MYELOMA PATIENTS AT PRIMARY DIAGNOSIS AND RELAPSE OR PROGRESSIVE DISEASE, Leukemia, 11, 1997, pp. 10-14
Authors:
GRAEFF H
WILMANNS W
JANICKE F
SAUER H
CLASSEN S
Citation: H. Graeff et al., BREAST-CANCER PROGNOSTIC AND THERAPY-RELE VANT FACTORS - RESULTS OF ACONSENSUS CONFERENCE, Onkologie, 20(5), 1997, pp. 426-429
Authors:
HEINEMANN V
BOSSE D
JEHN U
DEBUS A
WACHHOLZ K
FORST H
WILMANNS W
Citation: V. Heinemann et al., ENHANCED PULMONARY ACCUMULATION OF LIPOSOMAL AMPHOTERICIN-B (AMBISOME) IN ACUTE LIVER-TRANSPLANT FAILURE, Journal of antimicrobial chemotherapy, 40(2), 1997, pp. 295-297
Citation: M. Schleuning et al., THERAPEUTIC STRATEGY BASED ON SEMIQUANTITATIVE BCR-ABL PCR FOR MOLECULAR OR CYTOGENETIC RELAPSE AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR CHRONIC MYELOID-LEUKEMIA (CML), Experimental hematology, 25(8), 1997, pp. 622-622
Authors:
GERL A
LAMERZ R
MANN K
CLEMM C
WILMANNS W
Citation: A. Gerl et al., IS SERUM TUMOR-MARKER HALF-LIFE A GUIDE TO PROGNOSIS IN METASTATIC NONSEMINOMATOUS GERM-CELL TUMORS, Anticancer research, 17(4B), 1997, pp. 3047-3049
Authors:
DUELL T
MITTERMULLER J
SCHMETZER HM
KOLB HJ
WILMANNS W
Citation: T. Duell et al., CHRONIC MYELOID-LEUKEMIA ASSOCIATED HYPEREOSINOPHILIC SYNDROME WITH ACLONAL T(4-7)(Q11-Q32), Cancer genetics and cytogenetics, 94(2), 1997, pp. 91-94
Authors:
HEINEMANN V
BOSSE D
JEHN U
KAHNY B
WACHHOLZ K
DEBUS A
SCHOLZ P
KOLB HJ
WILMANNS W
Citation: V. Heinemann et al., PHARMACOKINETICS OF LIPOSOMAL AMPHOTERICIN-B (AMBISOME) IN CRITICALLYILL PATIENTS, Antimicrobial agents and chemotherapy, 41(6), 1997, pp. 1275-1280